 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
SUMMARIES FOR PATIENTS
Congenital Causes of Venous Thrombosis—A Classification System
21 January 2003 | Volume 138 Issue 2 | Page I-39
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine.
The summary below is from the full report titled "Congenital Thrombophilic States Associated with Venous Thrombosis: A Qualitative Overview and Proposed Classification System." It is in the 21 January 2003 issue of Annals of Internal Medicine (volume 138, pages 128-134). The authors are MA Crowther and JG Kelton.
What is the problem and what is known about it so far?
Some people are born with genetic or physiologic conditions that make them more likely to develop blood clots in their veins (venous thrombosis). Scientists have recently learned that these congenital problems, which include genetic mutations that affect proteins in blood that regulate clotting, are more common and more varied than had been thought. Researchers have also recently discovered that certain disorders are likely to affect younger people, while other conditions can cause clots at any age. They have also learned that some, but not all, coagulation problems may predispose patients to recurrent blood clots. Since much of the knowledge is new, the authors propose that classifying congenital blood-clotting problems into two major groups may help clinicians diagnose and treat their patients who develop venous thrombosis.
Why did the authors do this review?
Many of the conditions that predispose people to developing blood clots were discovered by scientists in the 1980s and 1990s. The authors suggest that because of rapid advances in the field, clinicians can better help their patients if they have a practical, evidence-based method for thinking about possible clotting problems.
How did the authors do this review?
Using MEDLINE, a National Library of Medicine service that enables computerized searches of the medical literature, the authors identified all articles published in English from 1998 to May 2001 that addressed inherited blood clotting conditions in humans.
What did the authors find?
Given the state of the knowledge about congenital problems that may cause patients to develop blood clots, the authors propose that these disorders be categorized into two general groups. The first group includes conditions that occur when a person has too little of what keeps blood from clotting too much (for example, antithrombin deficiencies). These are less common, but potentially more dangerous. About 60% of patients with these deficiencies will develop a blood clot by age 60 years. Patients with the second set of conditions have too much of the substances that cause blood to clot (prothrombin and other clotting factors). These disorders are more common in the population; however, patients with these disorders can develop blood clots at any age, and these disorders may not be risk factors for recurrent blood clotting problems. The authors also list several conditions that fall outside this classification system and point out that many patients with blood clots may have more than one risk factor for developing them.
What are the implications of the review?
Grouping congenital causes of venous thrombosis may help clinicians and patients think about their risk for developing blood clots. This, in turn, may lead them to consider whether certain treatments—such as medicine used to prevent blood clots forming—are right for them.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  J. E. Dalen Venous Thromboembolism and the Archives of Internal Medicine, 1908 to 2005 Arch Intern Med, January 14, 2008; 168(1): 14 - 15. [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Silverstein, K. A. Bauer, M. Cushman, C. T. Esmon, W. B. Ershler, and R. P. Tracy Venous thrombosis in the elderly: more questions than answers Blood, November 1, 2007; 110(9): 3097 - 3101. [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Stone, S. H. Silverman, and K. Nomoto Intracardiac Thrombosis and Acute Right Ventricular Failure Following Complex Reoperative Cardiac Surgery With Aprotinin and Deep Hypothermic Circulatory Arrest Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2007; 11(3): 177 - 184. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Marchiori, L. Mosena, M. H. Prins, and P. Prandoni The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies Haematologica, August 1, 2007; 92(8): 1107 - 1114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Austin, H. Cohen, and N. Losseff Haematology and neurology J. Neurol. Neurosurg. Psychiatry, April 1, 2007; 78(4): 334 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D Blann and G. Y H Lip Venous thromboembolism BMJ, January 28, 2006; 332(7535): 215 - 219. [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Beck and B. Berman Review of Thrombophilic States Clinical Pediatrics, April 1, 2005; 44(3): 193 - 199. [PDF]
|
|
|
|
 |
|
 G. A. Knoll, P. S. Wells, D. Young, S. L. Perkins, R. M. Pilkey, J. J. Clinch, and M. A. Rodger Thrombophilia and the Risk for Hemodialysis Vascular Access Thrombosis J. Am. Soc. Nephrol., April 1, 2005; 16(4): 1108 - 1114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Ginsburg Genetic Risk Factors for Arterial Thrombosis and Inflammation Hematology, January 1, 2005; 2005(1): 442 - 444. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cushman Inherited Risk Factors for Venous Thrombosis Hematology, January 1, 2005; 2005(1): 452 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. R. Buller, G. Agnelli, R. D. Hull, T. M. Hyers, M. H. Prins, and G. E. Raskob Antithrombotic Therapy for Venous Thromboembolic Disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 401S - 428S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. S. Donahue Factor V Leiden and Perioperative Risk Anesth. Analg., June 1, 2004; 98(6): 1623 - 1634. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article
